Ligand Pharmaceuticals Incorporated Common Stock logo

Ligand Pharmaceuticals Incorporated Common Stock (LGND) Technical Analysis

$302.74▲-3.08%

Market is closed - opens 7 PM, 02 Oct 2026

Insights

  • Ligand Pharmaceuticals Inc. is currently in a neutral trading position according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Ligand Pharmaceuticals Inc. stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Ligand Pharmaceuticals Inc. stock is in a uptrend ↗️
  • Based on analysis of the Pivot Points, the current market trend for Ligand Pharmaceuticals Inc. stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
56.98
Neutral
Stochastic
68.81, 81.27
Neutral
Ultimate Oscillator
52.55
Neutral
Stochastic Relative Strength Index
78.19, 88.58
Neutral
Moving Average Convergence Divergence
5.4, 2.92
Buy

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
301.06
Buy
20
292.7
Buy
50
291.72
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
301.75
Buy
20
296.44
Buy
50
290.53
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
301.43
Neutral
20
294.39
Neutral
50
293.6
Neutral

Double Exponential Moving Average

Period (Days)

Value

Action

10
308.88
Buy
20
302.63
Buy
50
300.3
Sell

Triple Exponential Moving Average

Period (Days)

Value

Action

10
311.11
Buy
20
307.76
Buy
50
297.36
Sell

Pivot

Pivot

Value

Resistance L3
327.7
Resistance L2
322.46
Resistance L1
317.42
Pivot Point
312.18
Support L1
307.14
Support L2
301.9
Support L3
296.86

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.